Viewing Study NCT01715168


Ignite Creation Date: 2025-12-24 @ 5:36 PM
Ignite Modification Date: 2025-12-27 @ 8:50 AM
Study NCT ID: NCT01715168
Status: UNKNOWN
Last Update Posted: 2015-01-15
First Post: 2012-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer
Sponsor: Azaya Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module